Science

Yüksel Ürün: Largest AI Mammography Trial, Game-Changer

Yüksel Ürün/X

Feb 8, 2025, 19:19

Yüksel Ürün: Largest AI Mammography Trial, Game-Changer

Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared an article by Veronica Hernström, et al. on LinkedIn:

“Largest AI Mammography Trial: Game-Changer!

105,934 women screened.
29% more cancers detected.
44% reduction in screen-reading workload.
No rise in false positives.

AI is reshaping breast cancer screening!”

Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study.

Authors: Veronica Hernström, et al.

Yüksel Ürün: Largest AI Mammography Trial, Game-Changer

AI Mammography Trial Ankara University School of Medicine artificial intelligence Breast Cancer cancer fight against cancer Global fight against cancer Mammography Trial MASAI MedOnc OncoDaily Oncology Veronica Hernström Yüksel Ürün

April is Head and Neck Cancer Awareness Month

Is Cancer Hereditary? Myths and Facts about Cancer Genetics

Neuroendocrine Lung Tumors: Types, Symptoms, Diagnosis, Treatment and 2025 updates

Cancer Center Near Me: Dana-Farber Cancer Institute

FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial